Literature DB >> 11192593

Chromogranins as diagnostic and prognostic markers in neuroendocrine tumours.

K Oberg1, M Stridsberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11192593     DOI： 10.1007/0-306-46837-9_26

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  10 in total

Review 1.  Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Rebecca M Minter; Diane M Simeone
Journal:  J Gastrointest Surg       Date:  2011-10-19       Impact factor: 3.452

Review 2.  Surgical treatment of liver metastases in patients with neuroendocrine tumors.

Authors:  Ahmad Saeed; Joseph F Buell; Emad Kandil
Journal:  Ann Transl Med       Date:  2013-04

Review 3.  Multimodal management of neuroendocrine liver metastases.

Authors:  Andrea Frilling; Georgios C Sotiropoulos; Jun Li; Oskar Kornasiewicz; Ursula Plöckinger
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

4.  Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe 1-Tyr 3-octreotide and chromogranin A assay in patients with neuroendocrine tumours.

Authors:  Margarida Rodrigues; Michael Gabriel; Dirk Heute; Daniel Putzer; Andrea Griesmacher; Irene Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-19       Impact factor: 9.236

5.  Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma.

Authors:  Alicia Algeciras-Schimnich; Carol M Preissner; William F Young; Ravinder J Singh; Stefan K G Grebe
Journal:  J Clin Endocrinol Metab       Date:  2007-10-16       Impact factor: 5.958

6.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

7.  Surgical treatment of liver metastases in neuroendocrine neoplasms.

Authors:  Palepu Jagannath; Deepak Chhabra; Shailesh Shrikhande; Rajiv Shah
Journal:  Int J Hepatol       Date:  2012-01-26

8.  Neuroendocrine tumors (NETs) - experience of a single Center.

Authors:  Mihaela Cornelia Şincu; Iuliu Gabriel Cocuz; Andreea Cătălina Tinca; Raluca Niculescu; Adrian Horaţiu Sabău; Diana Maria Chiorean; Silviu Horia Morariu; Ovidiu Simion Cotoi
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

9.  Chronic subacute bowel obstruction caused by carcinoid tumour misdiagnosed as irritable bowel syndrome: a case report.

Authors:  Henrietta M Wilson
Journal:  Cases J       Date:  2009-01-22

Review 10.  Hepatic arterial embolization in patients with neuroendocrine tumors.

Authors:  Michela Del Prete; Francesco Fiore; Roberta Modica; Vincenzo Marotta; Francesca Marciello; Valeria Ramundo; Antonella Di Sarno; Annachiara Carratù; Chiara de Luca di Roseto; Salvatore Tafuto; Fabiana Tatangelo; Robero Baldelli; Annamaria Colao; Antongiulio Faggiano
Journal:  J Exp Clin Cancer Res       Date:  2014-05-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.